Dr. Peruzzi is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
60 Fenwood Rd
#4186
Boston, MA 02115Phone+1 617-525-6454Fax+1 617-713-3050- Is this information wrong?
Summary
- Dr. Pier Paolo Peruzzi is a neurosurgeon in Boston, MA and is affiliated with Brigham and Women's Hospital. He received his medical degree from La Sapienza University of Rome and has been in practice 13 years. He also speaks multiple languages, including Italian. He specializes in brain & spinal tumors. Dr Peruzzi is a NIH-sponsored researcher and his laboratory investigates the role and therapeutic use of non-coding RNAs in malignant brain tumors. He is also the principal investigator of a clinical trial investigating the use of drug-releasing micro devices informing personalized chemotherapy for patients affected by gliomas.
Education & Training
Ohio State University HospitalResidency, Neurological Surgery, 2007 - 2014
Sapienza University of RomeClass of 2004
Certifications & Licensure
MA State Medical License 2015 - 2024
OH State Medical License 2007 - 2016- American Board of Neurological Surgery Neurological Surgery
Awards, Honors, & Recognition
- Academy Award American Academy of Neurological Surgery, 2018
- NREF research fellowship American Association of Neurological Surgeons, 2011
- R25 fellowship NIH, 2010
- Join now to see all
Clinical Trials
- Implantable Microdevice In Primary Brain Tumors Start of enrollment: 2020 Mar 03
Publications & Presentations
PubMed
- 12 citationsClinical trial links oncolytic immunoactivation to survival in glioblastoma.Alexander L Ling, Isaac H Solomon, Ana Montalvo Landivar, Hiroshi Nakashima, Jared K Woods, Andres Santos, Nafisa Masud, Geoffrey Fell, Xiaokui Mo, Ayse S Yilmaz, Jame...> ;Nature. 2023 Nov 1
- 3 citationsInaugural Results of the Individualized Screening Trial of Innovative Glioblastoma Therapy: A Phase II Platform Trial for Newly Diagnosed Glioblastoma Using Bayesian A...Rifaquat Rahman, Lorenzo Trippa, Eudocia Q Lee, Isabel Arrillaga-Romany, Geoffrey Fell, Mehdi Touat, Christine McCluskey, Jennifer Wiley, Sarah Gaffey, Jan Drappatz, M...> ;Journal of Clinical Oncology. 2023 Dec 20
- 4 citationsIntratumoral drug-releasing microdevices allow in situ high-throughput pharmaco phenotyping in patients with gliomas.Pierpaolo Peruzzi, Christine Dominas, Geoffrey Fell, Joshua D Bernstock, Sarah Blitz, Debora Mazzetti, Mykola Zdioruk, Hassan Y Dawood, Daniel V Triggs, Sebastian W Ah...> ;Science Translational Medicine. 2023 Sep 6
- Join now to see all
Press Mentions
The Hitchhiker's Guide to Defeating GlioblastomaJanuary 25th, 2019
Grant Support
- Harnessing artificial microRNA clusters against glioblastoma epigenetic plasticity and resistance to therapyNINDS2020–2025
- Characterization of a microRNA network regulating glioblastoma epigenetics, cell reprogramming and DNA repairNINDS2017–2022
- Characterizing miR-128 as a major regulator of epigenetic programming, and a potent sensitizer to radiation therapy in glioblastoma.NINDS2016–2018
Committees
- Member, Internal Review Board for Neuro-oncology DFCI/HMS Cancer Center 2020 - Present
- Member, Scientific Review Committee at DFCI 2019 - Present
Professional Memberships
- Member
Other Languages
- Italian
Hospital Affiliations
Brigham and Women's HospitalBoston, Massachusetts
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
